Trends

(Thaweesak Saengngoen/iStock via Getty Images Plus)

Recent FDA COVID-19 actions and updates

By Jenni Spinner

The agency has been busy with actions related to the virus behind the pandemic, keeping an eye on vaccinations, emerging variants, and other concerns.

(Who_I_am/iStock via Getty Images Plus)

Tech Innovations: June 2021

By Jenni Spinner

This month’s roundup of new equipment, materials, tech partnerships and other news includes items from Ajinomoto, Evonik, Quanticate, Pharmasol, and more.

Pic:getty/aelitta

DIA 2021 Annual Meeting

Skills of the future – and the future of work

By Rachel Arthur

Whether working in the pharmaceutical industry or in academia or government, the skills required to achieve, maintain and grow a career are vastly different today than they were 30 years ago. A session at DIA 2021 will put the spotlight on the skills...

Pic:getty/CG6images

FDA approves Biogen’s Alzheimer's drug, Aduhelm

By Rachel Arthur

The US Food and Drug Administration (FDA) has approved Biogen’s Aduhelm (aducanumab) for the treatment of Alzheimer’s: making it the first new treatment approved for the disease since 2003.

(adrian825/iStock via Getty Images Plus)

People on the Move: June 2021

By Jenni Spinner

This month’s roundup of hires, acquisitions, anniversaries, and other announcements includes news from Premier Research, Cytel, ACG, and other companies.

Follow us

Products

View more

Webinars